GLP-1 RA can be used in type 2 diabetics with CKD who have not reached their blood sugar goals with metformin and sodium-glucose cotransporter 2 (SGLT2) inhibitors or who cannot take those medications as CKD advances. Here, SLC5A2 is linked to chronic kidney disease.